All Articles Tagged With: "Risperdal"
Articles
Antipsychotics as Nursing Home Chemical Restraints Continue: Report
Despite warnings that indicate antipsychotic drugs can cause fatal side effects for certain elderly users, a new report suggests that nursing homes nationwide continue to routinely give residents the medications as a form of “chemical restraint” to keep them passive and docile.
Risperdal Lawsuit Ends in $1B Verdict Against Johnson & Johnson
Johnson & Johnson has been hit with a $1.2 billion verdict by an Arkansas judge, after a jury found the company guilty of hiding or minimizing the health risks associated with their antipsychotic Risperdal.
Antipsychotics During Pregnancy Linked to Infant Movement Problems
New research suggests that the use of some antipsychotic medications during pregnancy may increase the risk of movement problems for infants.
Heart Attack Risk Seen With Antipsychotics Among Dementia Patients
Among elderly patients with dementia, the use of popular antipsychotic drugs, such as Abilify, Risperdal, Seroquel and Zyprexa, may significantly increase the risk of a heart attack, according to the findings of a new study.
Risperdal Diabetes Lawsuit Ends in Defense Verdict
A New Jersey jury determined last week that Johnson & Johnson failed to provide adequate warning that the antipsychotic Risperdal could cause diabetes, but found that there was insufficient evidence to hold the company liable for a Nebraska man’s illness.
Nursing Home Antidepressant Use May Increase Risk of Falling
The use of some antidepressants among nursing home residents with dementia may increase the risk of falls, which can lead to serious injury or death, according to the findings of a new study.
Risperdal Settlement Over Illegal Marketing Reached for $1 Billion
Johnson & Johnson will pay the U.S. government more than $1 billion to settle claims that it illegally marketed the antipsychotic drug Risperdal, urging doctors to use it in ways never approved by the FDA.
Antipsychotic Diabetes Risk Among Children Identified in Study
The side effects of Seroquel, Risperdal, Zyprexa, Abilify and other antipsychotic drugs could increase the risk of children developing diabetes, according to the findings of a new study.
Off-Label Antipsychotic Use Exposes Patients to Bad Side Effects: Study
The potential side effects of atypical antipsychotics may do more harm than good when used off-label, according to the findings of a new study.
Childhood Antipsychotic Weight Gain Needs to be Highlighted: FDA Panel
An FDA advisory panel is urging federal health regulators to keep a close eye on the potential risk of diabetes and weight gain among children that could be caused by side effects of atypical antipsychotics, which include the popular medications Seroquel, Zyprexa, Risperdal and Abilify.
